IMMUNITYBIO INC
(NASDAQ: IBRX)
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.
7.650
-0.100
(-1.29%)
Range
7.540 - 8.068
(7%)
Open
7.770
Previous Close
7.750
Bid Price
2.790
Bid Volume
32
Ask Price
2.820
Ask Volume
8
Volume
4,922,791
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis